Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Achillion Pharmaceuticals (ACHN)

Achillion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACHN
DateTimeSourceHeadlineSymbolCompany
14/02/202021:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACHNAchillion Pharmaceuticals Inc
14/02/202018:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
12/02/202015:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
12/02/202012:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/02/202012:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/02/202011:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ACHNAchillion Pharmaceuticals Inc
03/02/202011:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
03/02/202011:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
03/02/202011:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
03/02/202011:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
19/12/201914:24GlobeNewswire Inc.Achillion Shareholders Approve Agreement to be Acquired by AlexionNASDAQ:ACHNAchillion Pharmaceuticals Inc
09/12/201915:00GlobeNewswire Inc.Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...NASDAQ:ACHNAchillion Pharmaceuticals Inc
22/11/201915:42PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...NASDAQ:ACHNAchillion Pharmaceuticals Inc
19/11/201912:30GlobeNewswire Inc.European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/11/201912:30GlobeNewswire Inc.Achillion Announces Clearance of Investigational New Drug Application for ACH-5228NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201921:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201921:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201921:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201912:30GlobeNewswire Inc.Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
06/11/201914:07GlobeNewswire Inc.Achillion Announces Data Presentations at the 61st American Society of Hematology Annual MeetingNASDAQ:ACHNAchillion Pharmaceuticals Inc
05/11/201922:07Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
01/11/201920:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
18/10/201922:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHNAchillion Pharmaceuticals Inc
18/10/201921:50PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.NASDAQ:ACHNAchillion Pharmaceuticals Inc
17/10/201922:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201921:55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201915:44PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201913:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201913:52Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201913:50PR Newswire (US)Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...NASDAQ:ACHNAchillion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACHN